HEADER NUCLEAR RECEPTOR 08-SEP-97 1ERR TITLE HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH TITLE 2 RALOXIFENE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN; COMPND 5 SYNONYM: ESTROGEN RECEPTOR, ER-LBD, ER-ALPHA; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: LIGAND-BINDING DOMAIN (DOMAIN E - RESIDUES 301-553) IN COMPND 8 COMPLEX WITH THE SELECTIVE ANTAGONIST RALOXIFENE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 STRAIN: JM109; SOURCE 6 VARIANT: C1857; SOURCE 7 GENE: ER ALPHA; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 10 EXPRESSION_SYSTEM_STRAIN: JM109; SOURCE 11 EXPRESSION_SYSTEM_VARIANT: C1857; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PEALPHA 35 KEYWDS NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, STEROID, ANTAGONIST EXPDTA X-RAY DIFFRACTION AUTHOR A.M.BRZOZOWSKI,A.C.W.PIKE REVDAT 5 15-MAY-13 1ERR 1 HETATM VERSN REVDAT 4 24-FEB-09 1ERR 1 VERSN REVDAT 3 01-APR-03 1ERR 1 JRNL REVDAT 2 04-NOV-98 1ERR 3 ATOM COMPND REMARK TITLE REVDAT 2 2 3 HETATM AUTHOR SEQADV CRYST1 REVDAT 2 3 3 JRNL HEADER TER CONECT REVDAT 1 16-SEP-98 1ERR 0 JRNL AUTH A.M.BRZOZOWSKI,A.C.PIKE,Z.DAUTER,R.E.HUBBARD,T.BONN, JRNL AUTH 2 O.ENGSTROM,L.OHMAN,G.L.GREENE,J.A.GUSTAFSSON,M.CARLQUIST JRNL TITL MOLECULAR BASIS OF AGONISM AND ANTAGONISM IN THE OESTROGEN JRNL TITL 2 RECEPTOR. JRNL REF NATURE V. 389 753 1997 JRNL REFN ISSN 0028-0836 JRNL PMID 9338790 JRNL DOI 10.1038/39645 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 3 NUMBER OF REFLECTIONS : 15433 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.299 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1565 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3502 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 100 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.016 ; 0.020 REMARK 3 ANGLE DISTANCE (A) : 0.035 ; 0.030 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.052 ; 0.050 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.030 ; 0.040 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : 0.205 ; 0.300 REMARK 3 MULTIPLE TORSION (A) : 0.313 ; 0.300 REMARK 3 H-BOND (X...Y) (A) : 0.189 ; 0.300 REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : 3.100 ; 7.000 REMARK 3 STAGGERED (DEGREES) : 22.600; 15.000 REMARK 3 TRANSVERSE (DEGREES) : 39.700; 20.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.739 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.639 ; 3.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.106 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.828 ; 3.000 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1ERR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-DEC-96 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9054 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15433 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 62.6 REMARK 200 DATA REDUNDANCY IN SHELL : 1.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.44600 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR REMARK 200 SOFTWARE USED: MLPHARE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% (W/V) PEG 4000, 0.2M MAGNESIUM REMARK 280 CHLORIDE, 50MM L-LYSINE, 0.1M SUCROSE, 5% 1,4-DIOXANE, 0.1M TRIS- REMARK 280 HCL, PH 8.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 52.26500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 26.84000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 52.26500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 26.84000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 CE1 HIS A 373 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 301 REMARK 465 LYS A 302 REMARK 465 LYS A 303 REMARK 465 ASN A 304 REMARK 465 SER A 305 REMARK 465 LEU A 306 REMARK 465 THR A 460 REMARK 465 PHE A 461 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 LEU A 469 REMARK 465 LYS A 529 REMARK 465 CYS A 530 REMARK 465 LYS A 531 REMARK 465 ASN A 532 REMARK 465 VAL A 533 REMARK 465 VAL A 534 REMARK 465 ARG A 548 REMARK 465 LEU A 549 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 THR A 553 REMARK 465 SER B 301 REMARK 465 LYS B 302 REMARK 465 LYS B 303 REMARK 465 ASN B 304 REMARK 465 SER B 305 REMARK 465 ASP B 332 REMARK 465 PRO B 333 REMARK 465 THR B 334 REMARK 465 ARG B 335 REMARK 465 PRO B 336 REMARK 465 PHE B 337 REMARK 465 SER B 338 REMARK 465 GLU B 339 REMARK 465 THR B 460 REMARK 465 PHE B 461 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 THR B 465 REMARK 465 LEU B 466 REMARK 465 LYS B 467 REMARK 465 SER B 468 REMARK 465 CYS B 530 REMARK 465 LYS B 531 REMARK 465 ASN B 532 REMARK 465 VAL B 533 REMARK 465 VAL B 534 REMARK 465 PRO B 535 REMARK 465 PRO B 552 REMARK 465 THR B 553 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 331 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP A 332 CG OD1 OD2 REMARK 470 GLU A 397 CD OE1 OE2 REMARK 470 LYS A 416 CG CD CE NZ REMARK 470 GLU A 419 CG CD OE1 OE2 REMARK 470 GLU A 470 CG CD OE1 OE2 REMARK 470 GLU A 471 CG CD OE1 OE2 REMARK 470 LYS A 472 CG CD CE NZ REMARK 470 ARG A 477 CZ NH1 NH2 REMARK 470 LYS A 492 CD CE NZ REMARK 470 GLU A 542 CG CD OE1 OE2 REMARK 470 HIS B 377 CG ND1 CD2 CE1 NE2 REMARK 470 GLU B 397 CD OE1 OE2 REMARK 470 LYS B 416 CG CD CE NZ REMARK 470 GLU B 419 CG CD OE1 OE2 REMARK 470 GLU B 423 CG CD OE1 OE2 REMARK 470 LEU B 469 CG CD1 CD2 REMARK 470 GLU B 470 CG CD OE1 OE2 REMARK 470 GLU B 471 CG CD OE1 OE2 REMARK 470 LYS B 472 CG CD CE NZ REMARK 470 ARG B 477 CZ NH1 NH2 REMARK 470 LYS B 529 CG CD CE NZ REMARK 470 ARG B 548 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 549 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 352 NE - CZ - NH2 ANGL. DEV. = -6.6 DEGREES REMARK 500 ARG A 394 CD - NE - CZ ANGL. DEV. = -11.5 DEGREES REMARK 500 ARG A 394 NE - CZ - NH1 ANGL. DEV. = -3.2 DEGREES REMARK 500 MET A 421 CA - CB - CG ANGL. DEV. = 14.3 DEGREES REMARK 500 SER A 432 N - CA - CB ANGL. DEV. = 9.8 DEGREES REMARK 500 ARG A 515 NE - CZ - NH2 ANGL. DEV. = -4.8 DEGREES REMARK 500 ASP B 313 CB - CG - OD1 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP B 313 CB - CG - OD2 ANGL. DEV. = -5.8 DEGREES REMARK 500 ASN B 359 CA - CB - CG ANGL. DEV. = -13.6 DEGREES REMARK 500 ASN B 359 OD1 - CG - ND2 ANGL. DEV. = 15.1 DEGREES REMARK 500 ARG B 363 NE - CZ - NH1 ANGL. DEV. = 5.4 DEGREES REMARK 500 GLU B 385 OE1 - CD - OE2 ANGL. DEV. = -7.3 DEGREES REMARK 500 ARG B 394 NE - CZ - NH1 ANGL. DEV. = -3.3 DEGREES REMARK 500 SER B 432 N - CA - CB ANGL. DEV. = 11.1 DEGREES REMARK 500 ARG B 434 CD - NE - CZ ANGL. DEV. = 8.7 DEGREES REMARK 500 ARG B 436 CD - NE - CZ ANGL. DEV. = 12.8 DEGREES REMARK 500 VAL B 446 CA - CB - CG1 ANGL. DEV. = 9.0 DEGREES REMARK 500 ARG B 503 NE - CZ - NH1 ANGL. DEV. = -5.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 332 96.30 -11.69 REMARK 500 PRO A 333 -91.32 -77.49 REMARK 500 PRO A 365 118.07 -39.77 REMARK 500 LEU A 408 69.20 -150.91 REMARK 500 GLU A 419 100.05 -41.76 REMARK 500 GLU B 397 36.64 -84.57 REMARK 500 HIS B 398 52.98 -142.42 REMARK 500 LEU B 408 74.17 -156.33 REMARK 500 CYS B 417 3.59 -61.21 REMARK 500 MET B 528 -83.81 -49.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ASP A 473 -13.89 REMARK 500 GLY B 457 11.28 REMARK 500 HIS B 501 -12.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RAL A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RAL B 600 DBREF 1ERR A 301 553 UNP P03372 ESR1_HUMAN 301 553 DBREF 1ERR B 301 553 UNP P03372 ESR1_HUMAN 301 553 SEQRES 1 A 253 SER LYS LYS ASN SER LEU ALA LEU SER LEU THR ALA ASP SEQRES 2 A 253 GLN MET VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE SEQRES 3 A 253 LEU TYR SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU SEQRES 4 A 253 ALA SER MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG SEQRES 5 A 253 GLU LEU VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO SEQRES 6 A 253 GLY PHE VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU SEQRES 7 A 253 LEU GLU CCS ALA TRP LEU GLU ILE LEU MET ILE GLY LEU SEQRES 8 A 253 VAL TRP ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE SEQRES 9 A 253 ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS CYS SEQRES 10 A 253 VAL GLU GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA SEQRES 11 A 253 THR SER SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU SEQRES 12 A 253 GLU PHE VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER SEQRES 13 A 253 GLY VAL TYR THR PHE LEU SER SER THR LEU LYS SER LEU SEQRES 14 A 253 GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE SEQRES 15 A 253 THR ASP THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU SEQRES 16 A 253 THR LEU GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU SEQRES 17 A 253 LEU ILE LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY SEQRES 18 A 253 MET GLU HIS LEU TYR SER MET LYS CYS LYS ASN VAL VAL SEQRES 19 A 253 PRO LEU TYR ASP LEU LEU LEU GLU MET LEU ASP ALA HIS SEQRES 20 A 253 ARG LEU HIS ALA PRO THR SEQRES 1 B 253 SER LYS LYS ASN SER LEU ALA LEU SER LEU THR ALA ASP SEQRES 2 B 253 GLN MET VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE SEQRES 3 B 253 LEU TYR SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU SEQRES 4 B 253 ALA SER MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG SEQRES 5 B 253 GLU LEU VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO SEQRES 6 B 253 GLY PHE VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU SEQRES 7 B 253 LEU GLU CCS ALA TRP LEU GLU ILE LEU MET ILE GLY LEU SEQRES 8 B 253 VAL TRP ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE SEQRES 9 B 253 ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS CYS SEQRES 10 B 253 VAL GLU GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA SEQRES 11 B 253 THR SER SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU SEQRES 12 B 253 GLU PHE VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER SEQRES 13 B 253 GLY VAL TYR THR PHE LEU SER SER THR LEU LYS SER LEU SEQRES 14 B 253 GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE SEQRES 15 B 253 THR ASP THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU SEQRES 16 B 253 THR LEU GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU SEQRES 17 B 253 LEU ILE LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY SEQRES 18 B 253 MET GLU HIS LEU TYR SER MET LYS CYS LYS ASN VAL VAL SEQRES 19 B 253 PRO LEU TYR ASP LEU LEU LEU GLU MET LEU ASP ALA HIS SEQRES 20 B 253 ARG LEU HIS ALA PRO THR MODRES 1ERR CCS A 381 CYS CARBOXYMETHYLATED CYSTEINE MODRES 1ERR CCS B 381 CYS CARBOXYMETHYLATED CYSTEINE HET CCS A 381 15 HET CCS B 381 10 HET RAL A 600 34 HET RAL B 600 34 HETNAM CCS CARBOXYMETHYLATED CYSTEINE HETNAM RAL RALOXIFENE FORMUL 1 CCS 2(C5 H9 N O4 S) FORMUL 3 RAL 2(C28 H27 N O4 S) FORMUL 5 HOH *100(H2 O) HELIX 1 1 ALA A 312 ASP A 321 1 10 HELIX 2 2 GLU A 339 ARG A 363 1 25 HELIX 3 3 PHE A 367 ASP A 369 5 3 HELIX 4 4 LEU A 372 SER A 395 1 24 HELIX 5 5 ARG A 412 CYS A 417 1 6 HELIX 6 6 VAL A 422 MET A 438 1 17 HELIX 7 7 GLY A 442 ASN A 455 1 14 HELIX 8 8 GLU A 471 LYS A 492 1 22 HELIX 9 9 LEU A 497 SER A 527 1 31 HELIX 10 10 LEU A 536 ASP A 545 1 10 HELIX 11 11 ALA B 307 SER B 309 5 3 HELIX 12 12 ALA B 312 ASP B 321 1 10 HELIX 13 13 MET B 342 ARG B 363 1 22 HELIX 14 14 PHE B 367 ASP B 369 5 3 HELIX 15 15 LEU B 372 SER B 395 1 24 HELIX 16 16 ARG B 412 CYS B 417 1 6 HELIX 17 17 MET B 421 MET B 437 1 17 HELIX 18 18 GLY B 442 ASN B 455 1 14 HELIX 19 19 GLU B 470 LYS B 492 1 23 HELIX 20 20 LEU B 497 MET B 528 1 32 HELIX 21 21 TYR B 537 LEU B 549 1 13 SHEET 1 A 2 LYS A 401 ALA A 405 0 SHEET 2 A 2 LEU A 408 ASP A 411 -1 N LEU A 410 O LEU A 402 SHEET 1 B 2 LYS B 401 ALA B 405 0 SHEET 2 B 2 LEU B 408 ASP B 411 -1 N LEU B 410 O LEU B 402 LINK C GLU A 380 N CCS A 381 1555 1555 1.33 LINK C CCS A 381 N ALA A 382 1555 1555 1.29 LINK C GLU B 380 N CCS B 381 1555 1555 1.31 LINK C CCS B 381 N ALA B 382 1555 1555 1.33 CISPEP 1 ARG A 335 PRO A 336 0 0.13 SITE 1 AC1 16 HOH A 3 LEU A 346 THR A 347 ALA A 350 SITE 2 AC1 16 ASP A 351 GLU A 353 LEU A 354 TRP A 383 SITE 3 AC1 16 LEU A 387 ARG A 394 PHE A 404 MET A 421 SITE 4 AC1 16 ILE A 424 HIS A 524 LEU A 525 LEU A 536 SITE 1 AC2 12 HOH B 61 LEU B 346 THR B 347 ALA B 350 SITE 2 AC2 12 ASP B 351 GLU B 353 TRP B 383 LEU B 391 SITE 3 AC2 12 ARG B 394 ILE B 424 HIS B 524 LEU B 536 CRYST1 104.530 53.680 102.710 90.00 116.79 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009567 0.000000 0.004830 0.00000 SCALE2 0.000000 0.018629 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010907 0.00000 MTRIX1 1 -0.740953 -0.502251 0.445794 74.86100 1 MTRIX2 1 -0.502316 -0.026089 -0.864290 122.90400 1 MTRIX3 1 0.445721 -0.864328 -0.232958 94.95000 1